Insights from 2023 WCLC
WCLC 2023 Insights: "PD-L1 Subgroups in the Phase 3 LUNAR Study - TTFields and Immune Checkpoint Inhibitor in mNSCLC"
By
Insights from 2023 WCLC
FEATURING
Rupesh Kotecha
By
Insights from 2023 WCLC
FEATURING
Rupesh Kotecha
Login to view comments.
Click here to Login
